Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from New Scientist
Explore the latest news, articles and features
Humans
Stunning collection of prehistoric engravings found in Spanish cave
News
Humans
British Iron Age ‘king’ who prompted Roman invasion was probably a woman
News
91ɫÇéƬ
Toothbrush that emits electricity may more effectively prevent gum disease
News
Twisteddoodles on scientific equipment training
Regulars
Popular articles
Trending New Scientist articles